Search research articles
Contact Us
Filters
Showing results (291-300 of 391) with videos related to
Page
of 40
Sort By:
Headache
|
November 24, 2019
Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine
Christoph P Hornik, Amy A Gelfand, Christina L Szperka, et al.
The Pediatric Infectious Disease Journal
|
May 26, 2012
Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation
Kevin M Watt, Daniel K Benjamin, Ira M Cheifetz, et al.
Anesthesia and Analgesia
|
November 20, 2019
Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass
Kanecia O Zimmerman, Huali Wu, Matthew Laughon, et al.
The Pediatric Infectious Disease Journal
|
December 19, 2013
Population pharmacokinetics of intravenous acyclovir in preterm and term infants
Mario R Sampson, Barry T Bloom, Robert W Lenfestey, et al.
Paediatric Drugs
|
August 12, 2018
A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents
Valentina Shakhnovich, P Brian Smith, Jeffrey T Guptill, et al.
Expert Review of Clinical Pharmacology
|
October 8, 2011
Innovative clinical trial design for pediatric therapeutics
Matthew M Laughon, Daniel K Benjamin, Edmund V Capparelli, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
April 5, 2019
Cefazolin pharmacokinetics in premature infants
Stephen J Balevic, P Brian Smith, Daniela Testoni, et al.
The Journal of Pediatrics
|
August 15, 2016
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates
Christoph P Hornik, Daniel K Benjamin, P Brian Smith, et al.
The Pediatric Infectious Disease Journal
|
January 26, 2018
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis
Julie Autmizguine, Sylvia Tan, Michael Cohen-Wolkowiez, et al.
Infectious Diseases and Therapy
|
February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions
Stephen J Balevic, Shruti M Raja, Rachel Randell, et al.
Page
of 40
Search research articles
Search
Showing results (291-300 of 391) with videos related to
Sort By:
Page
of 40
Headache
|
November 24, 2019
Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine
Christoph P Hornik, Amy A Gelfand, Christina L Szperka, et al.
The Pediatric Infectious Disease Journal
|
May 26, 2012
Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation
Kevin M Watt, Daniel K Benjamin, Ira M Cheifetz, et al.
Anesthesia and Analgesia
|
November 20, 2019
Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass
Kanecia O Zimmerman, Huali Wu, Matthew Laughon, et al.
The Pediatric Infectious Disease Journal
|
December 19, 2013
Population pharmacokinetics of intravenous acyclovir in preterm and term infants
Mario R Sampson, Barry T Bloom, Robert W Lenfestey, et al.
Paediatric Drugs
|
August 12, 2018
A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents
Valentina Shakhnovich, P Brian Smith, Jeffrey T Guptill, et al.
Expert Review of Clinical Pharmacology
|
October 8, 2011
Innovative clinical trial design for pediatric therapeutics
Matthew M Laughon, Daniel K Benjamin, Edmund V Capparelli, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
April 5, 2019
Cefazolin pharmacokinetics in premature infants
Stephen J Balevic, P Brian Smith, Daniela Testoni, et al.
The Journal of Pediatrics
|
August 15, 2016
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates
Christoph P Hornik, Daniel K Benjamin, P Brian Smith, et al.
The Pediatric Infectious Disease Journal
|
January 26, 2018
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis
Julie Autmizguine, Sylvia Tan, Michael Cohen-Wolkowiez, et al.
Infectious Diseases and Therapy
|
February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions
Stephen J Balevic, Shruti M Raja, Rachel Randell, et al.
Page
of 40